bluebird bio, Inc.
CD79A CHIMERIC ANTIGEN RECEPTORS
Last updated:
Abstract:
The invention provides improved compositions for adoptive cell therapies for cancers that express CD79A.
Status:
Application
Type:
Utility
Filling date:
14 Jun 2019
Issue date:
26 Aug 2021